Morgan Stanley’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $17K | Sell |
|
|||||
|
2022
Q2 | $64K | Sell |
|
|||||
|
2022
Q1 | $186K | Sell |
|
|||||
|
2021
Q4 | $708K | Buy |
|
|||||
|
2021
Q3 | $464K | Buy |
|
|||||
|
2021
Q2 | $480K | Buy |
|
|||||
|
2021
Q1 | $340K | Sell |
|
|||||
|
2020
Q4 | $365K | Buy |
|
|||||
|
2020
Q3 | $356K | Sell |
|
|||||
|
2020
Q2 | $743K | Buy |
|
|||||
|
2020
Q1 | $284K | Sell |
|
|||||
|
2019
Q4 | $627K | Sell |
|
|||||
|
2019
Q3 | $631K | Buy |
|
|||||
|
2019
Q2 | $1.1M | Buy |
|
|||||
|
2019
Q1 | $21K | Buy |
|